期刊文献+

正丁酸水杨酰芳胺酯类化合物的设计、合成及抗肿瘤活性 被引量:1

Design,synthesis and antitumor activity of n-butyric acid salicylanilide esters
原文传递
导出
摘要 目的:设计合成一系列正丁酸水杨酰芳胺酯类化合物并考察其体外抗肿瘤活性。方法:以不同的水杨酸与芳胺为原料经3步反应得到目标化合物;以K562,A549,A431细胞为靶细胞,MTT法与SRB法进行初步的体外抗肿瘤活性研究。结果与结论:合成了12个目标化合物,其结构经IR,1H-NMR,13C-NMR及MS确证。目标化合物对3种细胞株均具有不同程度的抑制活性,其中化合物6c,6f,6l抑制活性强于阳性对照药吉非替尼,与原药氯硝柳胺相当。 Objective: To design and synthesize a series of n-butyric acid salicylanilide esters,and to determine their anti-tumor activity.Methods: Different salicylic acids and aromatic amines were used as starting materials to synthesize target compounds through 3 steps.Anti-tumor activities of these compounds in K562,A549,A431 cells in vitro were investigated by MTT assay and SRB assay.Results and Conclusion: Twelve compounds were synthesized.Their structures were confirmed by IR,1H-NMR,13C-NMR and MS.The target compounds exhibited antitumor activities in these cells lines,and compounds 6c,6f,6l were found to have stronger cell growth inhibitory than gefitinib,and comparable to niclosamide.
出处 《中国新药杂志》 CAS CSCD 北大核心 2013年第14期1684-1690,1696,共8页 Chinese Journal of New Drugs
基金 安徽省自然科学基金(1208085MH128)
关键词 正丁酸 水杨酰芳胺 抗肿瘤活性 合成 n-abutyric acid salicylanilide antitumor activity synthesis
  • 相关文献

参考文献10

  • 1SUN L, MCMAHON G. Inhibition of tumor angiogenesis by syn- thetic receptor tyrosine kinase inhibitors [ J ]. Drugs Discov Today, 2000, 5(8) :344 -353. 被引量:1
  • 2SAVERIO M, PIER GP. Histone deacetylase inhibitors and the promise of epigenetic treatments for cancer[ J]. Nature, 2006, 6 (1) :38 -51. 被引量:1
  • 3CHRISTOPH L, URS S, GUIDO B, et al. Salieylanilides as inhibitors of the protein tyrosine kinase epidermal growth factor receptor[J]. EurJMedChem, 2004, 39(1):11-26. 被引量:1
  • 4YANG Y, SHI L, ZHOU Y, et al. Design, synthesis and biolog- ical evaluation of quinoline amide derivatives as novel VEGFR-2 inhibitors[ J ]. Bioorg Med Chem Lett, 2010, 20 ( 22 ) :6653 - 6656. 被引量:1
  • 5丁克,裴端卿,段磊,等.氯硝柳胺或其药学上可接受的盐的新用途:中国,CN101254183[P].2008-03-19. 被引量:1
  • 6丁克,裴端卿,李正伟,等.作为JAK-STAT3信号通路抑制剂的化合物的应用:中国,CN101537001[P].2009-09-23. 被引量:1
  • 7JIN YL, LU ZZ, DING K, et al. Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem ceils: Inactivation of the NF-KB pathway and generation of reactive oxygen species[J]. CancerRes, 2010, 70(6) :2516 -2527. 被引量:1
  • 8ENTIN MM, REPHAELI A, YANG XD, et al. Butyric acid prodrugs are histone deacetylase inhibitors that show antineoplastic activity and radiosensitizing capacity in the treatment of malignant gliomas[J]. Mol Cancer Ther, 2005, 4(12) :1952 -1961. 被引量:1
  • 9KAREL W, JOSEF M, HANA D, et al. The Oriented Development of Antituberculotics: Salicylanilides [ J ]. Arch Pharm Chem Life Sci, 2006, 339(11) :616 -620. 被引量:1
  • 10MUTO S. O-substituted hydroxyaryl derivatives: EP, 1512397A1 [P]. 2003-12-18. 被引量:1

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部